Last reviewed · How we verify
NCT06923332
A Trial to Assess the Effects of Diets With and Without Inulin on Energy Expenditure in Adults.
NA trial testing High Fiber bar with Inulin in Healthy in 61 participants. Completed in 19 September 2025.
19 September 2025
Quick facts
| Lead sponsor | Midwest Center for Metabolic and Cardiovascular Research |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | quadruple |
| Primary purpose | other |
| Enrollment | 61 |
| Start date | 7 April 2025 |
| Primary completion | 19 September 2025 |
| Estimated completion | 19 September 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- High Fiber bar with Inulin
- Low fiber bar - no inulin
Conditions studied
- Healthy — all drugs for Healthy →
- Overweight or Obese Adults — all drugs for Overweight or Obese Adults →
Sponsor
Midwest Center for Metabolic and Cardiovascular Research
Who can join
Adults 18 to 65, any sex, with Healthy or Overweight or Obese Adults. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this trial is to assess the effects of a 7-day diet containing inulin vs. a control diet on energy expenditure in adults with overweight/obesity or normal weight.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06923332
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Midwest Center for Metabolic and Cardiovascular Research trials
Trials by the same sponsor.
- NCT07293091 — Assessing the Appearance of Amino Acids in Circulation Following Consumption of Protein Beverages · NA · completed
- NCT07012317 — A Trial to Assess Gastrointestinal Responses to Dietary Fibers in Adults Using Weight Loss Medications · NA · completed
- NCT06494449 — Effect of Acute Intake of Meals Containing Higher vs. Lower Energy From Protein on DIT · NA · completed
- NCT06269094 — A Study to Understand How Continuous Glucose Monitors Impact Eating Behavior · NA · completed
- NCT06012669 — Effects of Lactoferrin at Two Doses vs. Active Control on Markers of Immune Function · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06923332 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Midwest Center for Metabolic and Cardiovascular Research
- Last refreshed: 25 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06923332.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing